Research Archives
Study links depression scores, white blood cell count
Dec. 2, 2021— by Emily Stembridge Researchers across four health care systems, including Vanderbilt University Medical Center, have found that increased depression polygenic scores are associated with increased white blood cell count, highlighting the importance of the immune system in the etiology of depression. Despite a wide understanding of depression as a psychiatric disorder, depression’s underlying biological...
Study provides new insight into how antidepressant drugs work
Dec. 1, 2021—A study by Vanderbilt researchers sheds light on how current antidepressant drugs work and suggests a new drug target in depression.
‘Multi-omics’ reveals treatment option for breast cancer subtype
Nov. 18, 2021— by Bill Snyder In a multidisciplinary collaboration, researchers at Vanderbilt University Medical Center and the University of Miami Miller School of Medicine have identified a subtype of triple-negative breast cancer (TNBC) that appears to be able to escape detection by the immune system and evade immunotherapy. Their report, published Nov. 1 in the journal...
Seven from VUMC among most highly cited researchers
Nov. 18, 2021—Seven Vanderbilt faculty members have made this year’s list of scientists whose papers have been cited most frequently by other researchers.
AI predicts 24-hour hospital discharge
Nov. 16, 2021—Vanderbilt researchers used a machine learning algorithm and data from more than 26,000 hospital stays to predict who would and would not be discharged over the next 24 hours.
Who’s who in the respiratory landscape
Nov. 15, 2021—A metatranscriptomics method developed by Vanderbilt researchers simultaneously characterizes viruses, microbiome and host response in nasal swabs, opening opportunities to explore molecular interactions directly in clinical samples.
CRISPR screen identifies new anti-inflammatory drug target
Nov. 11, 2021—A novel CRISPR screen developed by Vanderbilt researchers identified a promising new target for anti-inflammatory therapeutics.
The power of white matter
Nov. 11, 2021—Using a novel analysis of fMRI data, Vanderbilt researchers discovered intriguing patterns of signals in the brain’s white matter, the “conduit” for relaying signals between different brain regions.
New way to bEET insulin resistance
Nov. 11, 2021—Signaling molecules called EETs could improve insulin resistance, a primary risk factor for Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.
International gathering scrutinizes immune response, beta cell biology in Type 1 diabetes
Nov. 11, 2021— by Jill Clendening Nearly 400 investigators and scientific trainees hailing from 25 different countries recently gathered virtually, across continents and time zones, to share their latest research related to the immunology of Type 1 diabetes during the 18th Immunology of Diabetes Society (IDS) Congress, co-hosted by Vanderbilt University Medical Center and the University of...
Translational Research Forum honors scientific excellence
Nov. 11, 2021—Vanderbilt University Medical Center’s strength in translational research, which helps “translate” scientific discovery into medical practice, was celebrated recently during the Vanderbilt Translational Research Forum
Harrison Society researcher discovers key regulator of kidney cell structure
Nov. 4, 2021—New research from Vanderbilt could aid efforts to promote kidney regeneration after injury or to develop engineered organs.
